// App-Quantinova.ai

2841 : Healthcare Utilization and Costs Associated with Different Treatment Protocols for Newly Diagnosed Childhood Acute Lymphoblastic Leukemia: A Population-Based Study

Researchers

Presenter

  • Sumit Gupta

Principal Investigators

  • Nicole Mittman

  • Petros Pechlivanoglou

  • Qing Li

  • Uma Athale

  • Mylene Bassal

  • Vicky R. Breakey

  • Paul J. Gibson

  • Mariana Silva

  • Veda Zabih

  • Jason Pole

  • Rinku Sutradhar

Medical Centers

  • Haematology/Oncology, Hospital for Sick Children, Toronto, ON, Canada

  • Canadian Agency for Drugs and Technologies in Health, Ottawa, ON, Canada

  • Child Health Evaluative Sciences, The Hospital for Sick Children, Toronto, Canada

  • Cancer Research Program, Institute for Clinical Evaluative Sciences, Toronto, Canada

  • McMaster Children's Hospital, Division of Pediatric Hematology/Oncology, Hamilton, Canada

  • The Children's Hospital of Eastern Ontario, Ottawa, ON, Canada

  • McMaster Children's Hospital, Hamilton, ON, Canada

  • Children's Hospital, London Health Sciences Centre, London, Canada

  • Kingston General Hospital, Queens University , Kingston, ON, Canada

  • Pediatric Oncology Group of Ontario, Toronto, ON, Canada

  • Health Policy, Evaluation and Management, University of Toronto, Toronto, ON, Canada

  • Cancer Research Program, University of Toronto, Toronto, ON, Canada

Locations

  • Canada

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Acute lymphoblastic leukemia

  • Solid malignancies

Biomarkers

  • Breakpoint Cluster Region

Drug/Treatment

  • Asparaginase

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved